Literature DB >> 23623304

Betatrophin: a hormone that controls pancreatic β cell proliferation.

Peng Yi1, Ji-Sun Park, Douglas A Melton.   

Abstract

Replenishing insulin-producing pancreatic β cell mass will benefit both type I and type II diabetics. In adults, pancreatic β cells are generated primarily by self-duplication. We report on a mouse model of insulin resistance that induces dramatic pancreatic β cell proliferation and β cell mass expansion. Using this model, we identify a hormone, betatrophin, that is primarily expressed in liver and fat. Expression of betatrophin correlates with β cell proliferation in other mouse models of insulin resistance and during gestation. Transient expression of betatrophin in mouse liver significantly and specifically promotes pancreatic β cell proliferation, expands β cell mass, and improves glucose tolerance. Thus, betatrophin treatment could augment or replace insulin injections by increasing the number of endogenous insulin-producing cells in diabetics.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23623304      PMCID: PMC3756510          DOI: 10.1016/j.cell.2013.04.008

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  56 in total

1.  High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.

Authors:  G Zhang; V Budker; J A Wolff
Journal:  Hum Gene Ther       Date:  1999-07-01       Impact factor: 5.695

2.  Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.

Authors:  Yasuo Terauchi; Iseki Takamoto; Naoto Kubota; Junji Matsui; Ryo Suzuki; Kajuro Komeda; Akemi Hara; Yukiyasu Toyoda; Ichitomo Miwa; Shinichi Aizawa; Shuichi Tsutsumi; Yoshiharu Tsubamoto; Shinji Hashimoto; Kazuhiro Eto; Akinobu Nakamura; Mitsuhiko Noda; Kazuyuki Tobe; Hiroyuki Aburatani; Ryozo Nagai; Takashi Kadowaki
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Growth and regeneration of adult beta cells does not involve specialized progenitors.

Authors:  Monica Teta; Matthew M Rankin; Simon Y Long; Geneva M Stein; Jake A Kushner
Journal:  Dev Cell       Date:  2007-05       Impact factor: 12.270

4.  Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth.

Authors:  Jake A Kushner; Maria A Ciemerych; Ewa Sicinska; Lynn M Wartschow; Monica Teta; Simon Y Long; Piotr Sicinski; Morris F White
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

5.  Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function.

Authors:  Jeremy J Heit; Asa A Apelqvist; Xueying Gu; Monte M Winslow; Joel R Neilson; Gerald R Crabtree; Seung K Kim
Journal:  Nature       Date:  2006-09-21       Impact factor: 49.962

6.  Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice.

Authors:  Tohru Uchida; Takehiro Nakamura; Naoko Hashimoto; Tomokazu Matsuda; Ko Kotani; Hiroshi Sakaue; Yoshiaki Kido; Yoshitake Hayashi; Keiichi I Nakayama; Morris F White; Masato Kasuga
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

7.  Very slow turnover of beta-cells in aged adult mice.

Authors:  Monica Teta; Simon Y Long; Lynn M Wartschow; Matthew M Rankin; Jake A Kushner
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

8.  Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia.

Authors:  S G Rane; P Dubus; R V Mettus; E J Galbreath; G Boden; E P Reddy; M Barbacid
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

Review 9.  The biology of incretin hormones.

Authors:  Daniel J Drucker
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

10.  Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance.

Authors:  Terumasa Okada; Chong Wee Liew; Jiang Hu; Charlotte Hinault; M Dodson Michael; Jan Krtzfeldt; Catherine Yin; Martin Holzenberger; Markus Stoffel; Rohit N Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-06       Impact factor: 11.205

View more
  213 in total

1.  Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Authors:  Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

Review 2.  Development, growth and maintenance of β-cell mass: models are also part of the story.

Authors:  Anmar Khadra; Santiago Schnell
Journal:  Mol Aspects Med       Date:  2015-02-23

3.  In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats.

Authors:  Jiaxi Chen; Shuyuan Chen; Pintong Huang; Xing-Li Meng; Sandra Clayton; Jin-Song Shen; Paul A Grayburn
Journal:  Diabetologia       Date:  2015-02-28       Impact factor: 10.122

4.  Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.

Authors:  Young Lee; Eric D Berglund; Xinxin Yu; May-Yun Wang; Matthew R Evans; Philipp E Scherer; William L Holland; Maureen J Charron; Michael G Roth; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

5.  Metabolic disorders: Betatrophin boosts β-cells.

Authors:  Sarah Crunkhorn
Journal:  Nat Rev Drug Discov       Date:  2013-06-21       Impact factor: 84.694

6.  ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice.

Authors:  Robin Shoemaker; Frederique Yiannikouris; Sean Thatcher; Lisa Cassis
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-08-04       Impact factor: 4.310

Review 7.  Targeting the pancreatic β-cell to treat diabetes.

Authors:  Amedeo Vetere; Amit Choudhary; Sean M Burns; Bridget K Wagner
Journal:  Nat Rev Drug Discov       Date:  2014-02-14       Impact factor: 84.694

8.  Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis.

Authors:  Yan Wang; Fabiana Quagliarini; Viktoria Gusarova; Jesper Gromada; David M Valenzuela; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 9.  Advances in β cell replacement and regeneration strategies for treating diabetes.

Authors:  Jacqueline R Benthuysen; Andrea C Carrano; Maike Sander
Journal:  J Clin Invest       Date:  2016-10-03       Impact factor: 14.808

10.  A Pdx-1-Regulated Soluble Factor Activates Rat and Human Islet Cell Proliferation.

Authors:  Heather L Hayes; Lu Zhang; Thomas C Becker; Jonathan M Haldeman; Samuel B Stephens; Michelle Arlotto; Larry G Moss; Christopher B Newgard; Hans E Hohmeier
Journal:  Mol Cell Biol       Date:  2016-11-14       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.